Seridopidine( ACR343) is a dopaminergic active modulator developed by Neurosearch as an oral therapy for schizophrenia, Parkinson's disease, and Tourette's syndrome.

883631-51-4

C14H20FNO2S

285.38

ACR-343;ACR343;ACR 343;Seridopidine

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years